Friday, July 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,798
Companies 1,771
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,798 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 15 of 200 · By data quality, then INN

  1. erythromycin

    MAYNE PHARMA ERYTHROMYCIN Amneal Pharma Europe Ltd

    OPHTHALMIC FDA: approved · TGA: approved · NMPA: clinical trials

  2. erythromycin estolate

    ERYTHROMYCIN ESTOLATE Teva Pharma GmbH

    ORAL FDA: approved

  3. erythromycin ethylsuccinate

    E-MYCIN 200 Alphapharm Pty Ltd

    ORAL FDA: approved · TGA: approved

  4. erythromycin lactobionate

    ERYTHROMYCIN Teva Pharma GmbH

    INJECTION FDA: approved

  5. escitalopram oxalate

    ESCITALOPRAM OXALATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  6. eslicarbazepine acetate

    ZEBINIX S.A.

    ORAL FDA: approved · EMA: approved

    N03AF04

  7. esmolol hydrochloride

    ESMOLOL HYDROCHLORIDE Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  8. esomeprazole magnesium

    ESOMEPRAZOLE MAGNESIUM Amneal Pharma Europe Ltd

    ORAL FDA: approved

  9. estradiol

    ESTRADERM MX 50 NovoThirteen

    TOPICAL FDA: approved · TGA: approved · NMPA: clinical trials

  10. estradiol valerate

    DELESTROGEN Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  11. estrogens, conjugated synthetic a

    SYNTHETIC CONJUGATED ESTROGENS A Teva Pharma GmbH

    VAGINAL FDA: approved

  12. estropipate

    ESTROPIPATE Teva Pharma GmbH

    VAGINAL FDA: approved

  13. eszopiclone

    LUNIVIA Teva Pharma GmbH

    ORAL FDA: approved · EMA: application withdrawn

  14. eteplirsen

    EXONDYS Sarepta Therapeutics

    INTRAVENOUS FDA: approved · EMA: refused

    M09AX

  15. ethacrynic acid

    ETHACRYNIC ACID Amneal Pharma Europe Ltd

    ORAL FDA: approved

  16. ethinyl estradiol

    LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL Amneal Pharma Europe Ltd

    ORAL-21 FDA: approved

  17. ethosuximide

    ZARONTIN Teva Pharma GmbH

    ORAL FDA: approved · TGA: approved

  18. etirinotecan pegol

    ONZEALD Nektar Therapeutics UK Limited

    EMA: refused

    L01

  19. etodolac

    LODINE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  20. etoposide

    ETOPOPHOS Sandoz Pty Ltd

    ORAL FDA: approved · TGA: approved · NMPA: clinical trials

  21. etravirine

    INTELENCE Janssen-Cilag Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    J05AG04

  22. etripamil

    CARDAMYST Milestone Pharmaceuticals

    NASAL FDA: approved

  23. everolimus

    AFINITOR Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved

    L01XE10

  24. evinacumab

    EVKEEZA Ultragenyx UK Limited

    EMA: approved

    C10AX

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,798 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.